CRISPR-Cas9 engineered cell lines with IRF3 and IRF7 gene knockouts designed to enhance Morbillivirus replication and titers by up to 10-fold. Built on validated technology showing 5-20 fold increases in viral titers for...
Novel vaccine platform using parainfluenza virus 5 (PIV5) and Sendai virus (SeV) as vectors to express antigens of three major feline pathogens: feline herpesvirus 1, feline calicivirus, and feline panleukopenia virus. O...